Cardinal Health, Inc. Website

Cardinal Health, Inc.

NYSE-CAH

Basic

  • Market Cap

    $23.24B

  • EV

    $25.38B

  • Shares Out

    243.57M

  • Revenue

    $220.57B

  • Employees

    47,520

Margins

  • Gross

    3.35%

  • EBITDA

    1.26%

  • Operating

    0.94%

  • Pre-Tax

    0.42%

  • Net

    0.25%

  • FCF

    0.91%

Returns (5Yr Avg)

  • ROA

    -1.4%

  • ROTA

    -110%

  • ROE

    16.14%

  • ROCE

    12.4%

  • ROIC

    8.05%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $112.01

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $3,718M

  • Net Debt

    $2,136M

  • Debt/Equity

    -1.79

  • EBIT/Interest

    29.76

Growth (CAGR)

  • Rev 3Yr

    12.1%

  • Rev 5Yr

    8.97%

  • Rev 10Yr

    8.95%

  • Dil EPS 3Yr

    -17.22%

  • Dil EPS 5Yr

    195.16%

  • Dil EPS 10Yr

    8.28%

  • Rev Fwd 2Yr

    1.27%

  • EBITDA Fwd 2Yr

    10.15%

  • EPS Fwd 2Yr

    14.05%

  • EPS LT Growth Est

    13.26%

Dividends

  • Yield

  • Payout

    89.78%

  • DPS

    $2

  • DPS Growth 3Yr

    1.16%

  • DPS Growth 5Yr

    1%

  • DPS Growth 10Yr

    5.17%

  • DPS Growth Fwd 2Yr

    1.34%

Select a metric from the list below to chart it

Jun '14

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

LTM

Jun '24 (E)

Jun '25 (E)

Jun '26 (E)

Total Revenues

145,534

152,922

162,467

181,364

205,012

220,572

Total Revenues % Chg.

6.4%

5.1%

6.2%

11.6%

13%

11%

Cost of Goods Sold, Total

138,700

146,054

155,689

174,819

198,123

213,184

Gross Profit

6,834

6,868

6,778

6,545

6,889

7,388

Selling General & Admin Expenses, Total

4,480

4,572

4,533

4,557

4,834

5,029

Amortization of Goodwill and Intangible Assets

621

524

451

324

285

276

Other Operating Expenses, Total

5,101

5,096

4,984

4,881

5,119

5,305

Operating Income

1,733

1,772

1,794

1,664

1,770

2,083

Interest Expense, Total

-294

-238

-180

-149

-93

-70

Net Interest Expenses

-294

-238

-180

-149

-93

-70

Currency Exchange Gains (Loss)

-13

-11

-8

-7

-7

Other Non Operating Income (Expenses)

-2

12

55

-16

11

31

EBT, Excl. Unusual Items

1,424

1,535

1,661

1,499

1,681

2,037

Restructuring Charges

-125

-122

-114

-101

-95

-139

Merger & Related Restructuring Charges

Impairment of Goodwill

-2,100

-1,200

-1,008

Gain (Loss) On Sale Of Investments

579

-2

2

Gain (Loss) On Sale Of Assets

508

-60

Asset Writedown

-20

-7

-19

50

-50

19

Legal Settlements

-36

-5,741

-1,129

-109

302

17

Other Unusual Items

-16

-14

-10

EBT, Incl. Unusual Items

1,751

-3,772

323

-769

638

926

Income Tax Expense

386

-79

-289

163

376

373

Earnings From Continuing Operations

1,365

-3,693

612

-932

262

553

Earnings Of Discontinued Operations

Minority Interest

-2

-3

-1

-1

-1

-1

Net Income

1,363

-3,696

611

-933

261

552

Net Income to Common Incl Extra Items

1,363

-3,696

611

-933

261

552

Net Income to Common Excl. Extra Items

1,363

-3,696

611

-933

261

552

Total Shares Outstanding

299

293

291

273

251

244

Weighted Avg. Shares Outstanding

300

293

292

279

261

247.5

Weighted Avg. Shares Outstanding Dil

301

293

294

279

262

249.3

EPS

4.5

-12.6

2.1

-3.3

1

2.2

EPS Diluted

4.5

-12.6

2.1

-3.4

1

2.2

EBITDA

2,733

2,685

2,577

2,356

2,462

2,783

Effective Tax Rate

22%

2.1%

-89.5%

-21.2%

58.9%

40.3%